Guizhou Medical University is a public university based in Guiyang, capital of Guizhou province in China that offers courses in pharmacy, medical laboratory science, preventive medicine, nursing and clinical medicine, as well as other subject areas.

During the past decade, The Affiliated Hospital of Guizhou Medical University conducted 66 clinical trials. In the 10-year time frame, 66 clinical trials started and 6 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 3 clinical trials were completed. i.e. 7.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Affiliated Hospital of Guizhou Medical University" #1 sponsor was "Boehringer Ingelheim" with 5 trials, followed by "Guizhou Medical University" with 4 trials sponsored, "Pfizer" with 3 trials sponsored, "Capital Medical University" with 2 trials sponsored and "Chen Xiangmei" with 2 trials sponsored. Other sponsors include 56 different institutions and companies that sponsored additional 55 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Affiliated Hospital of Guizhou Medical University" #1 collaborator was "The Affiliated Hospital Of Guizhou Medical University" with 6 trials as a collaborator, "Beijing Tiantan Hospital" with 4 trials as a collaborator, "First Affiliated Hospital Xi'an Jiaotong University" with 4 trials as a collaborator, "General Hospital of Ningxia Medical University" with 4 trials as a collaborator and "Henan Provincial People's Hospital" with 4 trials as a collaborator. Other collaborators include 280 different institutions and companies that were collaborators in the rest 193 trials.

According to Clinical.Site data, the most researched conditions in "The Affiliated Hospital of Guizhou Medical University" are "Hemophilia A" (4 trials), "Stroke" (3 trials), "Acute Coronary Syndrome" (2 trials), "Alzheimer Disease" (2 trials) and "Analgesia" (2 trials). Many other conditions were trialed in "The Affiliated Hospital of Guizhou Medical University" in a lesser frequency.

Most popular intervention types in "The Affiliated Hospital of Guizhou Medical University" are "Drug" (58 trials), "Other" (4 trials), "Device" (3 trials), "Procedure" (3 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "placebo" (3 trials), "Abelmoschus manihot" (2 trials), "Abelmoschus manihot (AM)" (2 trials) and "Eptinezumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "The Affiliated Hospital of Guizhou Medical University" are 72 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are 35 active trials in "The Affiliated Hospital of Guizhou Medical University". 1 are not yet recruiting, 27 are recruiting, 5 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 18 completed trials in The Affiliated Hospital of Guizhou Medical University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Affiliated Hospital of Guizhou Medical University, 6 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 13 trials that are defined as “Not Applicable".

The Affiliated Hospital of Guizhou Medical University has several departments that took part in Clinical trials: "Guizhou Cancer Hospital" - 23 trials, "Center for Disease Control and Prevention, Guizhou Province" - 2 trials